Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 890 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR World No Tobacco Day 2024: European Societies call for an EU... May 30, 2024 Clinical Utility of ctDNA NGS for Detecting Actionable Alterations According ESCAT... September 26, 2022 Mental Health Awareness for Health Care Providers May 21, 2021 Cern και αντιμετώπιση του καρκίνου June 9, 2019 Load more HOT NEWS Cancer in My Community: Caring for Children With Cancer in Armenia EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab Genetic Counseling for Hereditary Breast Cancer: What People With a Family... Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of...
